Matthew Rees
Directeur/Membre du Conseil chez COPPER ROAD RESOURCES INC.
Fortune : 3 135 $ au 30/04/2024
Provenance du réseau au premier degré de Matthew Rees
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Precious Metals | 7 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Matthew Rees via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| GLOBEX MINING ENTERPRISES INC. | Precious Metals | Director of Finance/CFO | |
| PINETREE CAPITAL LTD. | Financial Conglomerates | Director of Finance/CFO | |
| PTX METALS INC. | Precious Metals | Director of Finance/CFO | |
| ENERGY FUELS INC. | Other Metals/Minerals | Chairman Director/Board Member | |
| SABRE GOLD MINES CORP. | Precious Metals | Director of Finance/CFO | |
| ESKAY MINING CORP. | Precious Metals | Director of Finance/CFO | |
| ROYAL STANDARD MINERALS INC. | Precious Metals | Chief Executive Officer | |
| GENSOURCE POTASH CORPORATION | Chemicals: Agricultural | Director/Board Member Director of Finance/CFO | |
| ODYSSEY RESOURCES LIMITED | Precious Metals | Director/Board Member Director/Board Member | |
| TINTINA MINES LIMITED | Other Metals/Minerals | Director/Board Member | |
| DYNACERT INC. | Trucks/Construction/Farm Machinery | Director of Finance/CFO | |
The Chartered Governance Institute
 The Chartered Governance Institute Miscellaneous Commercial ServicesCommercial Services The Chartered Governance Institute provides governance and compliance services. The company was incorporated by Royal Charter in 1891 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| INVENTUS MINING CORP. | Precious Metals | Director of Finance/CFO | |
| BE RESOURCES INC. | Other Metals/Minerals | Director/Board Member Chief Executive Officer | |
| MANITOU GOLD INC. | Precious Metals | Director of Finance/CFO | |
| G2 GOLDFIELDS INC. | Precious Metals | Corporate Secretary Director of Finance/CFO | |
| DEVERON CORP. | Packaged Software | Director of Finance/CFO | |
| GPM METALS INC. | Other Metals/Minerals | Corporate Secretary Director of Finance/CFO | |
| York University | College/University | Undergraduate Degree Undergraduate Degree | |
| MEGA URANIUM LTD. | Other Metals/Minerals | Director of Finance/CFO | |
| OUTDOORPARTNER MEDIA CORPORATION | Advertising/Marketing Services | Director/Board Member | |
| Institute of Chartered Secretaries & Administrators of Canada | Corporate Officer/Principal | ||
| Marrelli & Drake Corporate Services | Corporate Officer/Principal Corporate Officer/Principal | ||
| REVIVAL GOLD INC. | Precious Metals | Director of Finance/CFO | |
| DSA Corporate Services, Inc. | President Director/Board Member | ||
| ARANJIN RES | Other Metals/Minerals | Director of Finance/CFO | |
| NEW FRONTIER VENTURES INC. | Miscellaneous Commercial Services | Director of Finance/CFO | |
| BLUE LAGOON RESOURCES INC. | Other Metals/Minerals | Director of Finance/CFO | |
| SKYLIGHT HEALTH GROUP INC. | Medical/Nursing Services | Director of Finance/CFO | |
| AYR WELLNESS INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
79North Ltd.
 79North Ltd. Precious MetalsNon-Energy Minerals 79North Ltd. is an exploration stage company, which engages in the acquisition, exploration and development of mineral resource properties. It holds interest in Nassau, Sela Creek and Sandpiper Gold projects. The company was founded on August 15, 2016 and is headquartered in Toronto, Canada. | Precious Metals | Director of Finance/CFO | |
| REVIVE THERAPEUTICS LTD. | Pharmaceuticals: Major | Director of Finance/CFO | |
Revive Therapeutics, Inc.
 Revive Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Revive Therapeutics Ltd., Revive Therapeutics, Inc. is a specialty life sciences company based in North York, CA. The company focuses on the research and development of therapeutics for rare disorders and infectious diseases. Revive Therapeutics' cannabinoid pharmaceutical portfolio focuses on rare inflammatory areas such as liver disease. Revive Therapeutics was acquired by Mercury Capital II Ltd. on January 06, 2014 for $4.67 million. The Canadian company was granted FDA orphan drug status designation for the use of CBD to treat auto-immune hepatitis and ischemia and reperfusion injury from organ transplantation. The company is also exploring the use of bucillamine for the potential treatment of infectious diseases, including COVID-19. The company was founded by Fabio Chianelli. Revive recently acquired Psilocin Pharma Corp. to advance psilocybin-based therapeutics in various diseases and disorders. | Pharmaceuticals: Major | Director of Finance/CFO | |
| PHIVIDA HOLDINGS INC. | Pharmaceuticals: Other | Director of Finance/CFO | |
| OLIVE RESOURCE CAPITAL INC. | Precious Metals | Director of Finance/CFO | |
| MARTINA MINERALS CORP. | Precious Metals | Director of Finance/CFO | |
| SINTANA ENERGY INC. | Other Metals/Minerals | Director of Finance/CFO | |
| MAGNA GOLD CORP. | Precious Metals | Director of Finance/CFO |
Statistiques
Internationale
| Canada | 47 |
| Etats-Unis | 3 |
| Royaume-Uni | 2 |
| Mongolie | 2 |
Sectorielle
| Non-Energy Minerals | 28 |
| Finance | 9 |
| Health Technology | 5 |
| Commercial Services | 4 |
| Process Industries | 2 |
Opérationnelle
| Director of Finance/CFO | 94 |
| Director/Board Member | 59 |
| Corporate Secretary | 39 |
| Independent Dir/Board Member | 25 |
| President | 18 |
Relations les plus connectées
| Insiders | |
|---|---|
| Carmelo Marrelli | 106 |
| Mark Goodman | 27 |
| Shaun Drake | 25 |
| James Bovaird | 23 |
| Eric Szustak | 14 |
| John Timmons | 6 |
| Michael Waring | 3 |
- Bourse
- Insiders
- Matthew Rees
- Connexions Sociétés